TG Therapeutics Inc. (TGTX)
NASDAQ: TGTX
· Real-Time Price · USD
45.96
0.45 (0.99%)
At close: May 01, 2025, 2:49 PM
TG Therapeutics Revenue
TG Therapeutics reported an annual revenue of $329M, reflecting a 40.8% growth. For the quarter ending December 31, 2024, TG Therapeutics generated $108.19M in revenue.
Revenue (ttm)
$329M
Revenue Growth
40.8%
Price / Sales Ratio
13.29
Revenue / Employee
$973.38K
Employees
338
Market Cap
7.3B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 329M | +40.80% |
| Dec 31, 2023 | 233.66M | +8290.02% |
| Dec 31, 2022 | 2.79M | -58.36% |
| Dec 31, 2021 | 6.69M | +4300.66% |
| Dec 31, 2020 | 152K | n/a |